The AABB Annual Meeting brings together the latest research and practice-changing resources for the fields of blood and biotherapies. Colleagues from throughout the world attend to connect, network, learn and advance the field.
Science & Innovation Forum - The Impact of Red Blood Cell Transfusions on Biomarkers of Hemorrhagic Shock and Traumatic Brain Injury Please note: AABB reserves the right to make updates to this program. Presented by Hemanext®, an AABB Premium Corporate Partner. Optimizing healthcare for patients sustaining a traumatic brain injury is of major concern given […]
Hemanext is a privately held medical technology company dedicated to improving the quality, safety, efficacy, and cost of transfusion therapy. The company’s research and development efforts center on the study of hypoxically stored red blood cells (RBCs).LEARN ABOUT BLOOD QUALITY:Educational SymposiumsKey Abstracts and PublicationsPatient Advocacy GroupsRECENT NEWS: AABB RISE AWARDHemanext CONGRATULATES THE AUTHORS OF THE […]
Connect with Hemanext virtual booth at the 36th International Congress of Society of Blood Transfusions (ISBT). Learn about: Blood quality and potential impact on transfusion outcomes Potential benefits of hypoxic storage Hemanext’s vision to create a world with fewer, better transfusions Highlights: See Hemanext’s Processing System in action! View Hemanext’s accepted ISBT Abstracts Explore information […]